Daripro 40 Injection
Marketer
Anthem Biopharma
Salt Composition
Darbepoetin alfa (40mcg)
Overview Daripro 40 Injection
Epoetin alfa 40mg injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation to increase red blood cell production. Careful administration is crucial due to potential serious adverse effects; expert medical supervision is essential throughout treatment, strictly adhering to the physician's instructions. Common side effects encompass abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral swelling. Report symptoms of severe hypertension, including intense headache, visual disturbances, nausea, vomiting, or convulsions, immediately. Regular blood tests to monitor electrolyte levels (potassium), hemoglobin, and blood cell counts are typically ordered. Discontinue use and seek medical advice if shortness of breath or a skin rash develops. Prior to commencing treatment, disclose any history of cardiac disease, hypertension, seizures, or stroke. Pregnant, breastfeeding, or intending to become pregnant or breastfeed individuals should consult their physician regarding the drug's suitability.
Uses of Daripro 40 Injection
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Daripro 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Daripro 40 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Daripro 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Daripro 40 Injection works:
Daripro 40 Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by prompting the bone marrow—the blood cell-forming tissue within bones—to increase its output of red blood cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Daripro 40 Injection with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Daripro 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Daripro 40 Injection are likely incompatible. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Daripro 40 Injection.
KidneySAFE IF PRESCRIBED
Daripro 40 Injection poses no safety concerns for individuals with renal impairment; no dosage alteration is necessary.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Daripro 40 Injection, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Daripro 40 Injection :
Should you forget a Daripro 40 Injection dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Daripro 40 Injection
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | Erythropoietin-stimulating drug |






